Search research articles
Contact Us
Filters
Showing results (641-650 of 656) with videos related to
Page
of 66
Sort By:
EMBO Molecular Medicine
|
June 12, 2012
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
Robert J J O'Donoghue, Darryl A Knight, Carl D Richards, et al.
Plos Pathogens
|
May 5, 2022
Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection
Amanda J Lee, Emily Feng, Marianne V Chew, et al.
Journal of Palliative Medicine
|
March 14, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness
William E Rosa, Zachary Sager, Megan Miller, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
June 1, 1997
Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology
B F Barker, W M Carpenter, T E Daniels, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
May 17, 2020
A core outcome set for pre-eclampsia research: an international consensus development study
Jmn Duffy, A E Cairns, D Richards-Doran, et al.
The European Respiratory Journal
|
January 21, 2022
Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infection
Joshua J C McGrath, Gilles Vanderstocken, Anna Dvorkin-Gheva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
JCO Precision Oncology
|
September 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
Pat W Whitworth, Peter D Beitsch, Mary K Murray, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Annals of Surgical Oncology
|
April 5, 2022
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
Pat Whitworth, Peter D Beitsch, James V Pellicane, et al.
Page
of 66
Search research articles
Search
Showing results (641-650 of 656) with videos related to
Sort By:
Page
of 66
EMBO Molecular Medicine
|
June 12, 2012
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
Robert J J O'Donoghue, Darryl A Knight, Carl D Richards, et al.
Plos Pathogens
|
May 5, 2022
Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection
Amanda J Lee, Emily Feng, Marianne V Chew, et al.
Journal of Palliative Medicine
|
March 14, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness
William E Rosa, Zachary Sager, Megan Miller, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
June 1, 1997
Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology
B F Barker, W M Carpenter, T E Daniels, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
May 17, 2020
A core outcome set for pre-eclampsia research: an international consensus development study
Jmn Duffy, A E Cairns, D Richards-Doran, et al.
The European Respiratory Journal
|
January 21, 2022
Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infection
Joshua J C McGrath, Gilles Vanderstocken, Anna Dvorkin-Gheva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
JCO Precision Oncology
|
September 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
Pat W Whitworth, Peter D Beitsch, Mary K Murray, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Annals of Surgical Oncology
|
April 5, 2022
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
Pat Whitworth, Peter D Beitsch, James V Pellicane, et al.
Page
of 66